toplogo
Logga in

Automated Segmentation of Cervical Tumors and Gynecologic Organs Using a Compact Deep Learning Model


Centrala begrepp
A compact deep learning model, PocketNet, can accurately segment cervical tumors and gynecologic organs on T2-weighted MRI, enabling efficient and consistent radiotherapy planning for cervical cancer patients.
Sammanfattning

This study evaluated the performance of a two-stage PocketNet approach for automated segmentation of cervical tumors and gynecologic organs (cervix, uterus, vagina) on T2-weighted MRI in patients with cervical cancer undergoing definitive radiation therapy.

The key highlights are:

  1. PocketNet, a compact deep learning architecture, was used to segment the cervix, uterus, vagina, and tumor on T2-weighted MRI. PocketNet is designed to be computationally efficient while maintaining high segmentation accuracy.

  2. The model was trained and evaluated using a dataset of over 300 pre-treatment T2-weighted MRI scans from 102 cervical cancer patients. Manual segmentations by an experienced radiologist were used as ground truth.

  3. The two-stage PocketNet approach achieved a mean Dice-Sorensen similarity coefficient (DSC) of 80.98% for organ segmentation and 71.27% for tumor segmentation. The 95th percentile Hausdorff distance was 64.23 mm for organs and 38.59 mm for tumors.

  4. Qualitative evaluation showed that PocketNet performed well in accurately delineating the tumor and gynecologic organs in many cases, but also highlighted some challenging cases where the segmentation accuracy was lower.

  5. The compact nature of PocketNet makes it well-suited for deployment in resource-constrained clinical environments, while maintaining high segmentation performance compared to larger, more complex deep learning models.

  6. Further work is needed to expand the training dataset, incorporate additional imaging sequences, and validate the model's performance across multiple institutions to enable widespread clinical adoption of this automated segmentation approach.

edit_icon

Anpassa sammanfattning

edit_icon

Skriv om med AI

edit_icon

Generera citat

translate_icon

Översätt källa

visual_icon

Generera MindMap

visit_icon

Besök källa

Statistik
The average Dice-Sorensen similarity coefficient (DSC) for organ segmentation was 80.98% with a standard deviation of 1.22%. The average DSC for tumor segmentation was 71.27% with a standard deviation of 2.08%. The average 95th percentile Hausdorff distance was 64.23 mm for organs with a standard deviation of 65.85 mm. The average 95th percentile Hausdorff distance was 38.59 mm for tumors with a standard deviation of 56.28 mm.
Citat
"PocketNet achieved a mean Dice-Sorensen similarity coefficient (DSC) exceeding 70% for tumor segmentation and 80% for organ segmentation." "These results suggest that PocketNet is robust to variations in contrast protocols, providing reliable segmentation of the ROIs."

Viktiga insikter från

by Awj Twam, Me... arxiv.org 09-19-2024

https://arxiv.org/pdf/2409.11456.pdf
Two Stage Segmentation of Cervical Tumors using PocketNet

Djupare frågor

How can the performance of the PocketNet model be further improved, particularly for smaller tumors and challenging cases?

To enhance the performance of the PocketNet model, particularly for smaller tumors and challenging cases, several strategies can be employed. First, expanding the training dataset to include a more diverse range of tumor sizes, shapes, and imaging conditions is crucial. This would allow the model to learn from a broader spectrum of examples, improving its ability to generalize to smaller tumors that may have less distinct boundaries compared to larger masses. Second, incorporating advanced data augmentation techniques can help simulate variations in tumor appearance and enhance the model's robustness. Techniques such as rotation, scaling, and elastic deformations can create synthetic training examples that mimic the variability seen in clinical practice. Third, integrating additional imaging sequences, such as diffusion-weighted imaging (DWI), could provide complementary information that enhances the model's ability to differentiate between tumor and normal tissue. DWI is particularly useful for identifying regions of restricted diffusion that are characteristic of malignancies, potentially improving segmentation accuracy for smaller tumors. Lastly, implementing a multi-task learning approach, where the model is trained to perform both segmentation and classification tasks simultaneously, could improve its performance. By learning to classify tumor types or stages alongside segmentation, the model may develop a more nuanced understanding of the anatomical structures involved, leading to better segmentation outcomes.

What additional imaging modalities or clinical data could be integrated to enhance the robustness and accuracy of the automated segmentation?

To enhance the robustness and accuracy of automated segmentation in cervical cancer treatment, integrating additional imaging modalities and clinical data is essential. One promising approach is the incorporation of diffusion-weighted imaging (DWI), which provides information on tissue cellularity and can help distinguish between tumor and normal tissue more effectively. DWI can highlight areas of restricted diffusion that are often indicative of malignancy, thus improving segmentation accuracy, especially for smaller tumors. Furthermore, utilizing functional imaging techniques such as positron emission tomography (PET) could provide metabolic information that complements anatomical data from T2-weighted MRI. PET imaging can help identify areas of increased metabolic activity associated with tumors, aiding in more precise segmentation. In addition to imaging modalities, integrating clinical data such as histopathological findings, tumor markers, and patient demographics could enhance the model's contextual understanding. This information can be used to train the model to recognize patterns associated with different tumor types or stages, leading to improved segmentation performance. Lastly, incorporating longitudinal imaging data that tracks tumor changes over time could help the model learn to adapt to variations in tumor morphology, further enhancing its robustness and accuracy in clinical applications.

How can this automated segmentation approach be effectively integrated into the clinical workflow to support personalized radiation therapy planning for cervical cancer patients?

Integrating the automated segmentation approach using PocketNet into the clinical workflow for personalized radiation therapy planning involves several key steps. First, establishing a seamless interface between the imaging systems and the segmentation software is crucial. This integration would allow for real-time processing of T2-weighted MRI scans, enabling clinicians to receive automated segmentation results promptly. Second, training and educating clinical staff on the use of the automated segmentation tool is essential. Clinicians should understand the capabilities and limitations of the model, allowing them to interpret the results effectively and make informed decisions regarding treatment planning. Third, implementing a validation step where automated segmentations are reviewed by experienced radiologists or radiation oncologists can ensure accuracy and reliability. This hybrid approach, combining automated and manual segmentation, can help build trust in the system while allowing for continuous improvement of the model based on clinician feedback. Additionally, incorporating the automated segmentation results into treatment planning software can facilitate personalized radiation therapy. By providing accurate delineations of the tumor and surrounding organs at risk (OARs), clinicians can optimize radiation dose distributions, minimizing exposure to healthy tissues while maximizing tumor control. Finally, establishing a feedback loop where clinical outcomes are monitored and analyzed can help refine the model over time. By correlating segmentation accuracy with treatment outcomes, the model can be continuously improved, ultimately leading to better patient care and enhanced clinical outcomes for cervical cancer patients.
0
star